Williams Jones & Associates’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $19.9M | Sell |
182,426
-10,137
| -5% | -$1.11M | 0.41% | 59 |
|
|
2019
Q1 | $21.5M | Buy |
192,563
+1,515
| +0.8% | +$169K | 0.48% | 55 |
|
|
2018
Q4 | $18.4M | Sell |
191,048
-89,162
| -32% | -$8.6M | 0.5% | 54 |
|
|
2018
Q3 | $34.2M | Buy |
280,210
+1,694
| +0.6% | +$207K | 0.69% | 49 |
|
|
2018
Q2 | $30.6M | Sell |
278,516
-29,785
| -10% | -$3.27M | 0.67% | 50 |
|
|
2018
Q1 | $32.9M | Buy |
308,301
+6,214
| +2% | +$663K | 0.76% | 47 |
|
|
2017
Q4 | $32.3M | Buy |
302,087
+6,851
| +2% | +$731K | 0.73% | 47 |
|
|
2017
Q3 | $32.8M | Buy |
295,236
+17,568
| +6% | +$1.95M | 0.81% | 41 |
|
|
2017
Q2 | $28.7M | Buy |
277,668
+132,288
| +91% | +$13.7M | 0.72% | 44 |
|
|
2017
Q1 | $14.2M | Sell |
145,380
-62,031
| -30% | -$6.06M | 0.37% | 69 |
|
|
2016
Q4 | $18.3M | Sell |
207,411
-60,105
| -22% | -$5.32M | 0.52% | 52 |
|
|
2016
Q3 | $25.8M | Sell |
267,516
-10,131
| -4% | -$978K | 0.76% | 40 |
|
|
2016
Q2 | $23.8M | Buy |
277,647
+73,287
| +36% | +$6.29M | 0.73% | 45 |
|
|
2016
Q1 | $17.8M | Buy |
204,360
+111,606
| +120% | +$9.7M | 0.83% | 39 |
|
|
2015
Q4 | $10.5M | Sell |
92,754
-5,241
| -5% | -$591K | 0.48% | 61 |
|
|
2015
Q3 | $9.91M | Sell |
97,995
-1,338
| -1% | -$135K | 0.45% | 61 |
|
|
2015
Q2 | $12.2M | Sell |
99,333
-675
| -0.7% | -$83K | 0.47% | 61 |
|
|
2015
Q1 | $11.4M | Buy |
100,008
+4,242
| +4% | +$486K | 0.46% | 64 |
|
|
2014
Q4 | $9.68M | Buy |
95,766
+2,652
| +3% | +$268K | 0.4% | 71 |
|
|
2014
Q3 | $8.49M | Buy |
93,114
+1,410
| +2% | +$129K | 0.39% | 68 |
|
|
2014
Q2 | $7.86M | Sell |
91,704
-110,934
| -55% | -$9.5M | 0.35% | 72 |
|
|
2014
Q1 | $16M | Buy |
202,638
+98,766
| +95% | +$7.78M | 0.32% | 78 |
|
|
2013
Q4 | $7.86M | Buy |
103,872
+2,652
| +3% | +$201K | 0.38% | 71 |
|
|
2013
Q3 | $7.07M | Sell |
101,220
-450
| -0.4% | -$31.4K | 0.36% | 71 |
|
|
2013
Q2 | $5.89M | Buy |
+101,670
| New | +$5.89M | 0.29% | 84 |
|